Annex Advisory Services LLC Grows Stake in Colgate-Palmolive (NYSE:CL)

Annex Advisory Services LLC grew its stake in shares of Colgate-Palmolive (NYSE:CLFree Report) by 1,844.5% in the fourth quarter, Holdings Channel reports. The fund owned 76,905 shares of the company’s stock after acquiring an additional 72,950 shares during the quarter. Annex Advisory Services LLC’s holdings in Colgate-Palmolive were worth $6,991,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Liberty One Investment Management LLC raised its stake in shares of Colgate-Palmolive by 5.6% in the fourth quarter. Liberty One Investment Management LLC now owns 55,240 shares of the company’s stock valued at $5,022,000 after buying an additional 2,912 shares during the period. J2 Capital Management Inc purchased a new stake in Colgate-Palmolive in the 4th quarter worth about $294,000. Aaron Wealth Advisors LLC raised its stake in Colgate-Palmolive by 4.9% in the 4th quarter. Aaron Wealth Advisors LLC now owns 12,017 shares of the company’s stock valued at $1,092,000 after acquiring an additional 563 shares during the period. Sandy Cove Advisors LLC lifted its holdings in Colgate-Palmolive by 1.6% during the fourth quarter. Sandy Cove Advisors LLC now owns 17,236 shares of the company’s stock valued at $1,567,000 after purchasing an additional 279 shares during the last quarter. Finally, Astoria Portfolio Advisors LLC. lifted its holdings in Colgate-Palmolive by 39.6% during the fourth quarter. Astoria Portfolio Advisors LLC. now owns 2,909 shares of the company’s stock valued at $255,000 after purchasing an additional 825 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $88.79 on Monday. The stock has a market capitalization of $72.55 billion, a P/E ratio of 25.44, a price-to-earnings-growth ratio of 3.01 and a beta of 0.44. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The business’s 50 day simple moving average is $92.20 and its two-hundred day simple moving average is $97.75.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.25%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on CL shares. Piper Sandler lowered their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. Barclays cut their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday. Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Finally, UBS Group dropped their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Hold” and a consensus target price of $101.11.

Check Out Our Latest Analysis on Colgate-Palmolive

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.34% of the stock is currently owned by corporate insiders.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.